Login / Signup

Pilot Study of recurrent Ewing's Sarcoma management with Vigil/Temozolomide/Irinotecan and assessment of circulating tumor (ct) DNA.

Peter Meade AndersonMaurizio GhisoliBrian D CromptonKelly S KlegaLeonard H WexlerEmily K SlotkinLaura StanberyLuisa ManningGladice WallravenMeghan ManleyStaci HorvathErnest BognarJohn J Nemunaitis
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Results demonstrated safety of combination Vigil/TEM/IRI.
Keyphrases
  • circulating tumor
  • cell free
  • circulating tumor cells
  • image quality
  • computed tomography
  • dual energy
  • contrast enhanced
  • newly diagnosed
  • magnetic resonance imaging